A Note of Thanks
Peer review is the lifeblood of scientific publishing. To maintain the highest standards for the content of manuscripts published in Insulin, we seek independent reviewers from the faculties of medical schools and schools of pharmacy worldwide. Not only are our reviewers asked to provide in-depth reviews, but they are asked to do so within a short period of time.
Physicians' Corner - The Ever-Expanding Universe
Charles F. Shaefer, Jr., MD, FACP, FCCP
I've just finished reading a wonderful book titled, "A Short History of Nearly Everything." It's an engaging walk through science and theories relating to our universe, from "the very beginning" to the current time.
A Report from the 44th Annual Meeting of the European Association for the Study of Diabetes
The 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) is the most important European forum for diabetes discourse. The EASD encourages and supports research in the field of diabetes and the rapid diffusion of acquired knowledge. Members of the association include scientists, physicians, laboratory workers, nurses, and students from around the globe. Highlighted in this report are several presentations from the meeting that focused on real-life studies and the benefits of insulin therapy.
Use of U-500 Insulin in the Treatment of Severe Insulin Resistance
Elaine Cochran, MSN, CRNP, and Phillip Gorden, MD
Glycemic control is essential in the management of diabetes. However, many patients with diabetes are not achieving therapeutic targets, partly because they are receiving insufficient doses of insulin. This article presents an updated algorithm for the administration and dosing of U-500 insulin based on clinical experience with severe forms of insulin resistance. Guidelines are provided for dose escalation of U-500 insulin.
Weight Change in Intensive Insulin Therapy for Type 2 Diabetes Mellitus as a Function of Glycosylated Hemoglobin (A1C) Level Achieved: The Deep South Diabetes Program
JosAnn Duane, PhD, and William Conway, MD
The Deep South Diabetes Program conducted a retrospective study to evaluate weight changes associated with intensive basal-bolus insulin therapy. Results of the effectiveness of the treatment algorithm used in the study were published in the April 2008 issue of Insulin. This paper describes and evaluates further analyses of the results of the study.
Risk of Needlestick Injuries Among Nurses Using NovoFine Autocover Safety Needles and Nurses' Satisfaction with the Needles: The NOVAC Study
Odile Lautier, IDE, Helen Mosnier-Pudar, MD, Danielle Durain, IDE, Sophie Gonbert, MD, PhD, Luminita Spinu, MD, PhD, and Pierre Faure, DPharm
The Centers for Disease Control and Prevention has estimated that health care professionals endure between 600,000 and 1 million injuries from conventional needles and sharps annually in the United States and that >=1000 of these health care professionals contract serious infections annually from needlesticks and sharps. The NOVAC study compared the risk of needlestick injury with NovoFine Autocover needles and regular needles on insulin pens among nurses who administered insulin to patients.
Insulin Therapy: Questions This Issue
Anuj Bhargava, MD, MBA, CDE, FACP, FACE
How can I tell my patient with certainty that he has type 1 diabetes mellitus (DM)? Would the addition of an oral diabetes medication be effective in a patient with type 1 DM?
Responses to July 2008 Case Study
Derek LeRoith, MD, PhD
This was the case of a 28-year-old woman with a 25-year history of type 1 DM who visited her doctor for preconception counseling.
"Diabetes Tactics" Case Studies
Mazen Alsahli, MD, and John E. Gerich, MD, on behalf of CADRE
This month's "Diabetes Tactics" case discusses what to do when a patient is on maximal doses of metformin and a sulfonylurea and still has unsatisfactory glycemic control.
2009 Events Calendar
If you would like your event included in this list, please contact our Editorial Office.
Author Index
2008
Subject Index
2008
|
